Ocular presentations of breast cancer
- 20 September 2006
- journal article
- review article
- Published by Wiley in Acta Ophthalmologica Scandinavica
- Vol. 85 (2) , 133-142
Abstract
: Context: Breast cancer is the most common malignancy in women, with increasing incidence in Europe and North America. The frequency of involvement of the eye and visual pathways is reported to be as high as 30% in patients with known metastatic disease. In some cases, ophthalmic involvement can be the first sign of metastatic spread. Metastasis occurs via the haematogenous route and predominantly involves the choroid. Metastases to other ocular structures, the orbit and the visual pathways have also been described. Paraneoplastic effects are rare but significant.Treatments: Different modalities are employed in the treatment of breast cancer and its metastases. These include chemotherapy and radiotherapy. The ocular adverse effects of these have been well described, but recently developed new treatment modalities, such as monoclonal antibodies, may have different side‐effects. With the increasing incidence of breast cancer and the advent of new treatment strategies, the complications of the disease and the sequelae of therapy are highly relevant to both oncologists and ophthalmologists.Keywords
This publication has 94 references indexed in Scilit:
- Regression of choroidal metastases from breast carcinoma using aromatase inhibitorsBritish Journal of Ophthalmology, 2005
- Male Breast Cancer: Is the Incidence Increasing?Annals of Surgical Oncology, 2004
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002
- Canalicular stenosis secondary to docetaxel (taxotere)Ophthalmology, 2001
- Ocular toxicity in low-dose tamoxifen: A prospective studyEye, 1999
- Treatment of Breast CancerNew England Journal of Medicine, 1998
- Paraneoplastic disorders of neuro-ophthalmologic interestCurrent Opinion in Ophthalmology, 1996
- An unusual cause of diplopia in a cancer patientEuropean Journal of Cancer and Clinical Oncology, 1991
- An antineuronal autoantibody in paraneoplastic opsoclonusAnnals of Neurology, 1988
- Stevens-Johnson Syndrome during an Immunosuppressive Therapy with Cyclophosphamide and PrednisoneKlinische Padiatrie, 1985